1. MBRS-50. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Sajesh, Babu; On, Ngoc; Omar, Refaat; Fediuk, Holly; Li, Lin; Alrushaid, Samaa; Wang, W; Pu, J; Sun, H D; Siahaan, Teruna; Werbowetski-Ogilvie, Tamra; Wolfl, Matthias; Remke, Marc; Ramaswamy, Vijay; Taylor, Michael; Eberehart, Charles; Symons, Marc; Ruggieri, Rosa Maria; Miller, Donald; Vanan, Issai Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MBRS-50. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Sajesh, Babu; On, Ngoc; Omar, Refaat; Fediuk, Holly; Li, Lin; Alrushaid, Samaa; Wang, W; Pu, J; Sun, H D; Siahaan, Teruna; Werbowetski-Ogilvie, Tamra; Wolfl, Matthias; Remke, Marc; Ramaswamy, Vijay; Taylor, Michael; Eberehart, Charles; Symons, Marc; Ruggieri, Rosa Maria; Miller, Donald; Vanan, Issai Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗